August 29, 2025

Gastrointestinal Foreign Bodies: When to Use Computed Tomography Versus Radiograph

A physician-focused review of gastrointestinal foreign body ingestion is looking to guide triage and intervention.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 26, 2025

Can States Still Respond to Outbreaks?

Following court injunctions, some states and cities regained funding, while others experienced continued cancellations that affected immunization clinics, workforce capacity, and infectious-disease surveillance.

KFF Health News

August 25, 2025

What Does Xlear’s Lawsuit Mean for Physicians?

Xlear's xylitol maker sues the FTC to loosen evidence rules on health claims, signaling a deregulatory push that could reshape supplement marketing.

KFF Health News

August 22, 2025

New CT Score Tracks Pneumonia Stage Progression

Researchers validate a visual CT scoring system designed to improve classification of pneumonia-related lung changes in clinical and research settings.

Conexiant

August 22, 2025

Seven-Factor Tool Improves Sepsis Death Prediction

An admission-based model predicted 28-day mortality more accurately than SOFA and APACHE II, offering a potential tool for early risk stratification in ICU patients with sepsis secondary to pneumonia.

Conexiant

August 21, 2025

Final Overall Survival Analysis of FLAURA2: Osimertinib Plus Chemotherapy in EGFR-Mutant NSCLC

The final overall survival analysis demonstrates consistent survival benefit, as previously reported in the interim overall survival results, and builds on the previously presented primary endpoint da...

The ASCO Post